The subject has an identified, reliable, study partner (e.g., family member).

If using medications to treat symptoms related to AD, doses must be stable for at least 12 weeks prior to randomization.

You CAN'T join if...

Subject has any contraindications or inability to tolerate to brain magnetic resonance imaging (MRI), PET scans or lumbar puncture.

Subject has evidence of any other clinically significant neurological disorder other than Early AD.

In the opinion of the investigator, the subject has any clinically significant or uncontrolled medical or psychiatric illness, or has had an infection requiring medical intervention in the past 30 days.

Subject has had a myocardial infarction, unstable angina, stroke, transient ischemic attack or required intervention for any of these conditions within 6 months of Screening.

Locations

Univ California, San Franciscoaccepting new patientsSan Francisco, California, 94143-2204, United States

Irvine Clinical Researchaccepting new patientsIrvine, California, 92614, United States